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Tang and Lin, page 35
Efforts aimed at gaining insight into the genetic architec-
ture of complex-trait disorders turn, with increasing
frequency, to rare-variant association studies (RVASs).
Indeed, in recent years, many methods have been devel-
oped to detect rare variants that influence human traits.
The increase in large-scale sequencing studies suggests
that like genome-wide association studies (GWASs),
which study the association between common variants
and complex phenotypes, successful implementation of
RVASs might rely on the integration of data obtained
from multiple groups. However, whereas GWASs rely on
the genotyping of common variants, a consensus has
yet to emerge regarding the best way to perform meta-
analysis in the context of RVASs. When embarking on
an RVAS meta-analysis, one must consider several key
points—points that differ from those routinely imple-
mented in GWAS meta-analyses. In this issue, Tang and
Lin provide an overview of these considerations and
also describe PreMeta, a unified framework that inte-
grates the most popular RVAS meta-analysis packages.
Notably, PreMeta makes it possible for investigators to
combine summary statistics generated across different
platforms. Such a tool should be of great help for large,
multinational consortia, whose initial statistical analyses
are often performed on different platforms.Deletion Might Explain High-Altitude Adaptation
in Tibetans
Lou et al., page 54
Several studies of high-altitude adaptation have impli-
cated EPAS1 in conferring adaptation to low oxygen con-
ditions; however, the mechanism by which variation in
this region contributes to fitness is unclear. In this issue,
Lou et al. used WinXPCNVer to detect a previously iden-
tified, but not well-characterized, deletion in a Tibetan
population living at high altitude. Follow-up deep
sequencing in a second Tibetan population ruled out
additional structural variation at this locus. Because the
deletion was identified in 90% of Tibetans and only
3% of other worldwide populations, it is referred to as
a Tibetan-enriched deletion (TED). Testing based on
extended haplotype homozygosity supports the idea1Scientific Editor, AJHG; 2Deputy Editor, AJHG
http://dx.doi.org/10.1016/j.ajhg.2015.06.006. 2015 by The American Societthat the TED might underlie the signal of positive selec-
tion previously observed in the region. Indeed, the TED
lies near EPAS1 and is in linkage disequilibrium (LD)
with variants influencing hemoglobin concentrations.
Interestingly, the TED is in complete LD with an intro-
gressed Denisovan SNP motif. The TED itself is absent
from the Denisovan genome, however, suggesting that
the deletion was acquired at some point after introgres-
sion. The TED is estimated to have originated 13,000
years ago—the same time at which the Tibetan popula-
tion underwent an expansion. Future studies to identify
the potential functional consequences of the TED will
help to determine whether the deletion itself confers a se-
lective advantage or whether it is in LD with a functional
variant.When Did that Mutation Occur?
Acuna-Hidalgo et al., page 67
Many researchers undertake a search for de novo muta-
tions when they wish to discover the genetic cause of a
disease that appears not to run in families. This approach,
most often a trio analysis focusing on the unaffected par-
ents and the affected child, has proven successful in both
small- and large-scale sequencing projects. Although
some rare diseases, for example, overgrowth conditions
such as Proteus syndrome, have been attributed to so-
matic mutations affecting only a subset of an individual’s
cells, the underlying assumption is that most deleterious
mutations arise during gametogenesis and are present in
all cells. New findings from Acuna-Hidalgo et al. chal-
lenge this paradigm and instead suggest that many appar-
ently de novo mutations actually represent somatic
mosaicism; that is, the mutations arise during early devel-
opment or are passed along from a parent who harbors
the mutation in just a subset of their cells (and who
might therefore be unaffected or experience only mild
symptoms). Similar to recent findings related to somatic
mosaicism for copy-number variation, these new results
serve as an important reminder that one’s genome is
not identical across all cells in the body. Indeed, the au-
thors estimate that over 6% of an individual’s genetic
variation stems from somatic mosaicism. If confirmed,
these findings could have far-reaching implications for
the ways in which disease risk is estimated and prospec-
tive parents are counseled.y of Human Genetics. All rights reserved.
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A TWIST2 the Story
Marchegiani et al., page 99
In this issue, Marchegiani et al. provide evidence that
two congenital ectodermal dysplasias, ablepharon-macro-
stomia syndrome (AMS) and Barber-Say syndrome (BSS),
share more than just overlapping clinical features.
Through careful phenotyping and sequencing, the authors
demonstrated that recurrent de novo mutations in
TWIST2 cause both disorders. Interestingly, all identified
mutations affect the same amino acid in TWIST2; however,
whereas a p.Glu75Lys substitution was identified in all of
the study’s AMS-affected individuals, a p.Glu75Gln change
was found in all individuals with BSS. TWIST2 encodes a
transcription factor whose activity has been implicated
in diverse developmental processes, including stem cell
differentiation. The authors’ work in zebrafish and cell-cul-
ture models supports the idea that the altered TWIST2 pro-
teins could function in either a dominant-negative or a
neomorphic fashion. It is possible that the mutants differ-
entially titrate the wild-type TWIST2 away from its hetero-
dimeric binding partners, perhaps enacting distinct down-
stream transcriptional programs. Further experimentation
will be necessary for testing these ideas and reaching an
understanding of exactly how the two substitutions are
able to lead to such discrete outcomes; the answers should
provide insight into the genetic underpinnings of AMS
and BBS, as well as normal TWIST2 function.2 The American Journal of Human Genetics 97, 1–2, July 2, 2015Human Phenotype Ontology: Now Taking On
Common Disease
Groza et al., page 111
The Human Phenotype Ontology (HPO) has been widely
used in the rare disease community to aid in diagnosis
and identification of disease-associated candidate genes
by drawing upon more than 11,000 terms to describe
phenotypes that might be encountered in a clinical eval-
uation. However, the HPO was not optimized for com-
mon disease, and the utility for such an application has
been unclear. Now, Groza et al. have expanded the
HPO by including information mined from over five
million abstracts, generating over 130,000 annotations
for 3,145 common diseases. After they incorporated these
new annotations, a highly significant phenotype network
showed dense clusters and patterns that reflect the
phenotypic continuum, supporting the use of the data-
mining approach for producing the database. In a
demonstration of how the HPO can be used, the authors
investigated the similarities between the networks of phe-
notypes to look for shared underlying etiologies, and
they identified overlaps between common and rare or
Mendelian conditions. Ongoing curation of the HPO to
improve annotations and phenotypes will enhance its
value as a bioinformatics tool for common disease, in
addition to its established role in the rare-disease
community.
